Perrigo Company plc (PRGO) To Go Ex-Dividend on March 2nd

Perrigo Company plc (NYSE:PRGO) declared a quarterly dividend on Thursday, February 19th. Stockholders of record on Monday, March 2nd will be given a dividend of 0.29 per share on Tuesday, March 24th. This represents a c) dividend on an annualized basis and a dividend yield of 7.8%. The ex-dividend date is Monday, March 2nd.

Perrigo has increased its dividend payment by an average of 0.1%annually over the last three years and has increased its dividend annually for the last 23 consecutive years. Perrigo has a payout ratio of 35.5% indicating that its dividend is sufficiently covered by earnings. Analysts expect Perrigo to earn $3.06 per share next year, which means the company should continue to be able to cover its $1.16 annual dividend with an expected future payout ratio of 37.9%.

Perrigo Price Performance

Shares of NYSE:PRGO opened at $14.97 on Friday. The company has a current ratio of 2.51, a quick ratio of 1.44 and a debt-to-equity ratio of 0.81. The stock has a market cap of $2.06 billion, a PE ratio of -39.38, a price-to-earnings-growth ratio of 1.34 and a beta of 0.39. The stock’s fifty day simple moving average is $14.30 and its two-hundred day simple moving average is $17.81. Perrigo has a 1-year low of $12.17 and a 1-year high of $30.93.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. Zacks Research upgraded shares of Perrigo from a “strong sell” rating to a “hold” rating in a report on Friday, February 13th. Canaccord Genuity Group reduced their target price on Perrigo from $40.00 to $20.00 and set a “buy” rating for the company in a report on Thursday, November 6th. Argus raised Perrigo to a “hold” rating in a research report on Wednesday, January 14th. Wall Street Zen cut Perrigo from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Finally, JPMorgan Chase & Co. decreased their target price on Perrigo from $20.00 to $18.00 and set a “neutral” rating for the company in a research report on Monday, December 15th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $20.33.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.